Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia
- PMID: 20571403
- DOI: 10.1097/CEJ.0b013e32833c1bcb
Retinol supplementation and mesothelioma incidence in workers earlier exposed to blue asbestos (Crocidolite) at Wittenoom, Western Australia
Abstract
Owing to the high rates of malignant mesothelioma in workers exposed to crocidolite earlier at Wittenoom and evidence of protection against cancer by vitamin A, a population-based cancer prevention programme providing retinol supplements (25 000 IU/day) was commenced in 1990. The former workers at Wittenoom known to be alive and living in Western Australia in June 1990 constitute the study population. The participants were classified into two groups: those who received supplemental retinol (intervention group) and those who received none (comparison group). The relative rate of mesothelioma for those receiving retinol was estimated using Cox regression, adjusting for cumulative asbestos exposure and age at first exposure to asbestos. Nine hundred and twenty-eight former Wittenoom workers received retinol at some stage of the programme, whereas 1471 workers never received retinol (comparison group). Those who received retinol were younger, had a greater exposure to asbestos and smoked less than the comparison group. There were 65 cases of mesothelioma in the retinol group and 88 in the comparison group. After adjustment, the hazard ratio was 0.99 (95% confidence interval=0.70-1.41). This result did not alter when the participants who received only retinol once or those who received beta-carotene earlier were excluded from the analysis. In conclusion, this study provides little support for possible preventive effects of retinol against mesothelioma in workers exposed to blue asbestos.
Similar articles
-
Update of potency factors for asbestos-related lung cancer and mesothelioma.Crit Rev Toxicol. 2008;38 Suppl 1:1-47. doi: 10.1080/10408440802276167. Crit Rev Toxicol. 2008. PMID: 18671157
-
Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom.Occup Environ Med. 2008 Aug;65(8):541-3. doi: 10.1136/oem.2007.034280. Epub 2007 Nov 28. Occup Environ Med. 2008. PMID: 18045848
-
Epidemiology of malignant mesothelioma in Western Australia.Med J Aust. 1984 Jul 21;141(2):86-8. Med J Aust. 1984. PMID: 6330509
-
An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.Regul Toxicol Pharmacol. 2008 Oct;52(1 Suppl):S154-86. doi: 10.1016/j.yrtph.2007.09.020. Epub 2007 Oct 22. Regul Toxicol Pharmacol. 2008. PMID: 18396365 Review.
-
Epidemiology of malignant mesothelioma in Australia.Lung Cancer. 2004 Aug;45 Suppl 1:S21-3. doi: 10.1016/j.lungcan.2004.04.010. Lung Cancer. 2004. PMID: 15261428 Review.
Cited by
-
Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up.Br J Cancer. 2012 Feb 28;106(5):1016-20. doi: 10.1038/bjc.2012.23. Epub 2012 Feb 7. Br J Cancer. 2012. PMID: 22315054 Free PMC article.
-
Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.PLoS One. 2014 Aug 5;9(8):e103025. doi: 10.1371/journal.pone.0103025. eCollection 2014. PLoS One. 2014. PMID: 25093718 Free PMC article.
-
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.Expert Rev Respir Med. 2015 Oct;9(5):633-54. doi: 10.1586/17476348.2015.1081066. Epub 2015 Aug 26. Expert Rev Respir Med. 2015. PMID: 26308799 Free PMC article. Review.
-
Malignant pleural mesothelioma: some progress, but still a long way from cure.J Thorac Dis. 2018 Mar;10(3):1172-1177. doi: 10.21037/jtd.2018.01.152. J Thorac Dis. 2018. PMID: 29708163 Free PMC article. No abstract available.
-
Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma.Oncoscience. 2024 May 23;11:53-57. doi: 10.18632/oncoscience.605. eCollection 2024. Oncoscience. 2024. PMID: 38784478 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical